Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 211

1.

Do we know enough about the immune pathogenesis of acute coronary syndromes to improve clinical practice?

Matusik P, Guzik B, Weber C, Guzik TJ.

Thromb Haemost. 2012 Sep;108(3):443-56. doi: 10.1160/TH12-05-0341. Epub 2012 Aug 7. Review.

PMID:
22872109
2.

Update on acute coronary syndromes: the pathologists' view.

Falk E, Nakano M, Bentzon JF, Finn AV, Virmani R.

Eur Heart J. 2013 Mar;34(10):719-28. doi: 10.1093/eurheartj/ehs411. Epub 2012 Dec 13. Review.

3.

Cytokines, macrophage lipid metabolism and foam cells: implications for cardiovascular disease therapy.

McLaren JE, Michael DR, Ashlin TG, Ramji DP.

Prog Lipid Res. 2011 Oct;50(4):331-47. doi: 10.1016/j.plipres.2011.04.002. Epub 2011 May 13. Review.

PMID:
21601592
4.

Stabilisation of atherosclerotic plaques. Position paper of the European Society of Cardiology (ESC) Working Group on atherosclerosis and vascular biology.

Ylä-Herttuala S, Bentzon JF, Daemen M, Falk E, Garcia-Garcia HM, Herrmann J, Hoefer I, Jukema JW, Krams R, Kwak BR, Marx N, Naruszewicz M, Newby A, Pasterkamp G, Serruys PW, Waltenberger J, Weber C, Tokgözoglu L.

Thromb Haemost. 2011 Jul;106(1):1-19. doi: 10.1160/TH10-12-0784. Epub 2011 Jun 14. Review.

PMID:
21670845
5.

Role of vascular inflammation in coronary artery disease: potential of anti-inflammatory drugs in the prevention of atherothrombosis. Inflammation and anti-inflammatory drugs in coronary artery disease.

Moreira DM, da Silva RL, Vieira JL, Fattah T, Lueneberg ME, Gottschall CA.

Am J Cardiovasc Drugs. 2015 Feb;15(1):1-11. doi: 10.1007/s40256-014-0094-z. Review.

PMID:
25369900
6.

Inflammation in atherosclerosis: transition from theory to practice.

Libby P, Okamoto Y, Rocha VZ, Folco E.

Circ J. 2010 Feb;74(2):213-20. Epub 2010 Jan 9. Review.

7.

Pleiotropic effects of statins: stabilization of the vulnerable atherosclerotic plaque?

Akdim F, van Leuven SI, Kastelein JJ, Stroes ES.

Curr Pharm Des. 2007;13(10):1003-12. Review.

PMID:
17430164
8.

Anti-inflammatory strategies for plaque stabilization after acute coronary syndromes.

Baruch A, van Bruggen N, Kim JB, Lehrer-Graiwer JE.

Curr Atheroscler Rep. 2013 Jun;15(6):327. doi: 10.1007/s11883-013-0327-7. Review. Erratum in: Curr Atheroscler Rep. 2013 Dec;15(12):374.

PMID:
23636864
9.
10.

Inflammation and atherosclerosis: novel insights into plaque formation and destabilization.

Stoll G, Bendszus M.

Stroke. 2006 Jul;37(7):1923-32. Epub 2006 Jun 1. Review.

11.

Anti-inflammatory effects of anti-platelet treatment in atherosclerosis.

Arazi HC, Badimon JJ.

Curr Pharm Des. 2012;18(28):4311-25. Review.

PMID:
22236116
12.

Statins induce the accumulation of regulatory T cells in atherosclerotic plaque.

Meng X, Zhang K, Li J, Dong M, Yang J, An G, Qin W, Gao F, Zhang C, Zhang Y.

Mol Med. 2012 May 9;18:598-605. doi: 10.2119/molmed.2011.00471.

13.

Pluripotential mechanisms of cardioprotection with HMG-CoA reductase inhibitor therapy.

Rosenson RS.

Am J Cardiovasc Drugs. 2001;1(6):411-20. Review.

PMID:
14728000
14.
15.

Update on the efficacy of statin treatment in acute coronary syndromes.

Rosa GM, Carbone F, Parodi A, Massimelli EA, Brunelli C, Mach F, Vuilleumier N, Montecucco F.

Eur J Clin Invest. 2014 May;44(5):501-15. doi: 10.1111/eci.12255. Review.

PMID:
24601937
16.

Targeting the unstable plaque in acute coronary syndromes.

Thompson PL, Nidorf SM, Eikelboom J.

Clin Ther. 2013 Aug;35(8):1099-107. doi: 10.1016/j.clinthera.2013.07.332. Review.

PMID:
23973042
17.

Macrophage activation in atherosclerosis: pathogenesis and pharmacology of plaque rupture.

Boyle JJ.

Curr Vasc Pharmacol. 2005 Jan;3(1):63-8. Review.

PMID:
15638783
18.

The role of inflammation and allergy in acute coronary syndromes.

Ozben B, Erdogan O.

Inflamm Allergy Drug Targets. 2008 Sep;7(3):136-44. Review.

PMID:
18782020
19.

Inflammation, C-reactive protein, and atherothrombosis.

Ridker PM, Silvertown JD.

J Periodontol. 2008 Aug;79(8 Suppl):1544-51. doi: 10.1902/jop.2008.080249. Review.

PMID:
18673009
20.

Reverse vessel remodeling but not coronary plaque regression could predict future cardiovascular events in ACS patients with intensive statin therapy--the extended JAPAN-ACS study.

Miyauchi K, Daida H, Morimoto T, Hiro T, Kimura T, Nakagawa Y, Yamagishi M, Ozaki Y, Kadota K, Kimura K, Hirayama A, Kimura K, Hasegawa Y, Uchiyama S, Matsuzaki M; JAPAN-ACS Investigators.

Circ J. 2012;76(4):825-32.

Items per page

Supplemental Content

Write to the Help Desk